Human COX-2 quantitates human COX-2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human COX-2.
Human COX-2 quantitates human COX-2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human COX-2.
COX-2 converts the arachidonate to prostaglandin H2 (PGH2), a step involved in prostanoid synthesis, including the production of inflammatory prostaglandins. The conversion of l的arachidonate to prostaglandin H2 is a two-step reaction: a cyclooxygenase reaction (COX) that converts l的arachidonate to prostaglandin G2 (PGG2) and a peroxidase reaction in which PGG2 is reduced to prostaglandin H2 (PGH2). It is expressed constitutively in certain tissues under physiological conditions, such as the endothelium, kidney and brain, and is regulated from the top under pathological conditions, such as cancer and inflammation (unlike the PTGS1 enzyme, which is expressed ubiquitously). Increased regulation of COX-2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumour angiogenesis. In cancer cells, COX-2 is a key step in the production of prostaglandin E2 (PGE2), which plays an important role in the modulation of motility, proliferation and resistance to apoptosis. COX-2 is naturally inhibited by calcitriol (active form of vitamin D). Glucocorticoids chronically suppress PTGS2 gene activity in vivo in part by interfering with transcription initiation and elongation. COX-2 is a target of d-AINS such as the aspirin, which can reduce pain and swelling due to inflammation caused by COX-2.
Sensitivity
Sensitivity of the assay: 1.2 ng/mL.
Measurement range
Dose range: 1.2 to 300 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17144403 |
| Specifications |
| Accession number | Coii; Co x 2; COX-2; cyclooxygenase; cyclooxygenase 2; Cyclooxygenase 2 b; cyclooxygenase-2; polypeptide C oxidase cytochrome II; cytochrome c oxidase subunit 2; cytochrome c oxidase subunit II; glucocorticoid-regulated inflammatory cyclooxygenase; Gripghs; HCOX- |
| Dose range | 1.2 to 300 ng/mL |
| Sensitivity of the dosage | 1.2 ng/mL |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P35354 |
| Gene symbol(s) | PTGS2 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | COX2 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; Serum, 50 µl; Supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH125RB |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3822 19 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.